Your session is about to expire
← Back to Search
This trial is for OCD patients who have completed a different study protocol and are now looking for aftercare treatment options.
- Obsessive-Compulsive Disorder
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You are currently having suicidal thoughts or plans.
- Group 1: Pharmacotherapy
- Group 2: Psychotherapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment for this experiment still ongoing?
"Affirmative. The records posted on clinicaltrials.gov reveal that this research project, which was initially established in June 2017, is actively enrolling new participants. At present, 200 patients need to be recruited from a single site."
How many participants have been accepted into this clinical investigation?
"Yes, the information on clinicaltrials.gov denotes that this medical trial is actively enrolling. The project was first posted on June 23rd 2017 and most recently revised on May 13th 2020. This study seeks to recruit 200 participants from a single site."
Share this study with friends